# Study of CYR-064 Versus Placebo in Patients.

> **NCT06019000** · PHASE2 · COMPLETED · sponsor: **Cyrano Therapeutics, Inc.** · enrollment: 151 (actual)

## Conditions studied

- Hyposmia

## Interventions

- **COMBINATION_PRODUCT:** CYR-064

## Key facts

- **NCT ID:** NCT06019000
- **Lead sponsor:** Cyrano Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-26
- **Primary completion:** 2025-11-11
- **Final completion:** 2025-11-21
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06019000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06019000, "Study of CYR-064 Versus Placebo in Patients.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06019000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*